TELEPIED: Evaluation of the Management of Diabetic Foot Ulcers by Telemedicine on the Number of Hospital Days in Diabetic Patients

Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète (Other)
Overall Status
Completed
CT.gov ID
NCT02986256
Collaborator
(none)
180
1
2
40.2
4.5

Study Details

Study Description

Brief Summary

The TELEPIED project aims to show that it is possible to reduce the number of hospitalization days of a patient with ulcers of the foot thanks to a new organization of care, based on the intervention of a coordinating nurse interacting with the nurse in charge of the patient thanks to a telemedicine tool allowing the transfer of photos and ensuring itself a regular follow-up of the evolution of the wound and adapting the support nurse to the home if necessary.

It is a monocenter, randomized, in parallel study, in 180 diabetic patients with ulcers of the foot.

Patients included in the conventional group will be followed according to the usual practice Patients included in the "telepied" group will benefit from a personalized accompaniment by a nurse referring to diabetic foot ulcers who will guide and advise the nurse at home by acting by delegating tasks of the investigator.

The patient will be visited by the referring nurse every 15 days. During these visits, the referring nurse will have the objective to evaluate the evolution of the ulcer as well as the care performed. This visit also allows a close personalized accompaniment for the patient, who will benefit from an education adapted to the characteristics of ulcer (discharge modalities for example ..) and its way of life.

Every patients will be followed for one year (12 months).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Taking pictures
  • Behavioral: Visit at home
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Comparative Study, Randomized in Parallel Groups, Evaluating the Consequences of the Management of Diabetic Foot Ulcers by Telemedicine Versus Conventional Monitoring on the Number of Hospital Days in Diabetic Patients
Actual Study Start Date :
Jan 4, 2017
Actual Primary Completion Date :
May 12, 2020
Actual Study Completion Date :
May 12, 2020

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Conventionnal Group

No intervention for this group. Patients will be followed by a usual care.

Experimental: "Telepied" Group

Patients will be followed by a nurse referring to ulcers of the diabetic foot.

Behavioral: Taking pictures
Photograph of foot ulcer with transmission to referring nurse 1 time per week

Behavioral: Visit at home
Home visit by the referring nurse every 15 days

Outcome Measures

Primary Outcome Measures

  1. Number of hospitalization days related to diabetic foot ulcers after one year of follow-up [12 months]

Secondary Outcome Measures

  1. Total direct care costs between the Telepied group and the control group [12 months]

    hospitalization costs, transport costs, nursing costs, liberal nursing costs, material costs, number of consultations with the doctor

  2. Average duration of hospitalizations for an ulcer of the foot in the Telepied group versus the control group [12 months]

  3. Ulcer recidivism rate in the Telepied group versus control group. [12 months]

  4. Frequency of ulceration [12 months]

  5. Duration of ulceration [12 months]

  6. Healing rate between the Telepied group and the control group [12 months]

  7. Amputation rate between the two groups [12 months]

  8. Patient satisfaction score [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients over 18 years

  • Diabetic patients with foot ulcer

  • Patient who agreed to participate in the study and sign free and informed consent

  • Patient affiliated to a social security scheme

Exclusion Criteria:
  • Pregnant Woman

  • Patient deprived of liberty by a judicial or administrative decision or a person subject to a legal protection measure

  • Patient already involved in another clinical trial protocol

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Sud-Francilien Corbeil-Essonnes France 91100

Sponsors and Collaborators

  • Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Investigators

  • Principal Investigator: Dured Dardari, MD, Centre Hospitalier Sud Francilien

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
ClinicalTrials.gov Identifier:
NCT02986256
Other Study ID Numbers:
  • 2016-A01136-45
First Posted:
Dec 8, 2016
Last Update Posted:
Jun 5, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 5, 2020